Details for New Drug Application (NDA): 211328
✉ Email this page to a colleague
The generic ingredient in HALOETTE is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.
Summary for 211328
Tradename: | HALOETTE |
Applicant: | Dr Reddys Labs Sa |
Ingredient: | ethinyl estradiol; etonogestrel |
Patents: | 0 |
Pharmacology for NDA: 211328
Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 211328
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HALOETTE | ethinyl estradiol; etonogestrel | RING;VAGINAL | 211328 | ANDA | Mayne Pharma Inc. | 51862-148 | 51862-148-03 | 3 POUCH in 1 CARTON (51862-148-03) / 21 d in 1 POUCH (51862-148-01) |
HALOETTE | ethinyl estradiol; etonogestrel | RING;VAGINAL | 211328 | ANDA | Dr. Reddy's Labratories Inc. | 75907-088 | 75907-088-13 | 3 POUCH in 1 CARTON (75907-088-13) / 21 d in 1 POUCH (75907-088-11) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | RING;VAGINAL | Strength | 0.015MG/24HR;0.12MG/24HR | ||||
Approval Date: | Aug 5, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription